Drug intelligence / Profile preview

chm-1

Development stage
Preclinical
Lead developer
China Medical University
Modality
Small Molecules
Administration
Intravenous
01

Overview

CHM-1 is a small molecule compound described chemically as 2'-fluoro-6,7-methylenedioxy-2-phenyl-4-quinolone. It is a potent, selective antitumor agent shown to induce apoptosis (programmed cell death) in various human cancer cell lines, including hepatocellular carcinoma and ovarian cancer. CHM-1 acts as a vascular disrupting agent and exhibits antiangiogenic properties by inducing apoptosis in human endothelial cells and is noted for upregulating death receptor 5 (DR5) expression via p53 and p38 MAPK pathways, resulting in caspase-dependent apoptotic signaling. Its phosphate prodrug, CHM-1-P, also demonstrates significant antitumor activity in animal models[1][3][5].

Other names
2'-fluoro-6,7-methylenedioxy-2-phenyl-4-quinolonechm 1chm1chm-1
02

Targets

CASP8 (Caspase-8)CASP3 (Caspase-3)RK (Ribokinase)TP53 (Cellular Tumor Antigen p53 R175H)TNFRSF10B (DR5)

Beyond the preview

Go deeper on chm-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chm-1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call